409 filings
Page 15 of 21
8-K
cwgpshx23gm
2 Apr 12
GlaxoSmithKline to increase its ownership in Theravance
12:00am
8-K
13ssi3un aeqy
23 Mar 12
Other Events
12:00am
8-K
fvpzvow 6dx4cjkoihh0
16 Feb 12
Regulation FD Disclosure
12:00am
8-K
dgaha34
9 Feb 12
Results of Operations and Financial Condition
12:00am
8-K
t6z5 3qosy
9 Jan 12
Other Events
12:00am
8-K
g2d tmjxn1077kcsiry
6 Jan 12
Entry into a Material Definitive Agreement
12:00am
8-K/A
prfk2 ro3zp
2 Dec 11
Other Events
12:00am
8-K
757523758pdbdo i1q
17 Nov 11
Other Events
12:00am
8-K
i88y9et1bf8l5vwmgvp
14 Nov 11
Regulation FD Disclosure
12:00am
8-K
dvx6m
27 Oct 11
Other Events
12:00am
8-K
l94leuks1zmm5 xv
27 Oct 11
Results of Operations and Financial Condition
12:00am
8-K
jo67zr
26 Sep 11
Dose-related efficacy of GSK573719, a new long-acting muscarinic receptor antagonist (LAMA) offering sustained 24-hour bronchodilation in COPD
12:00am
8-K
tamc8aw2ppk
15 Sep 11
Other Events
12:00am
8-K
64329kc mgf
28 Jul 11
Results of Operations and Financial Condition
12:00am
8-K
bfks2fvrisidi4c18tc
2 Jun 11
Results Support Continuation of Relovair Development Programme in COPD
12:00am
8-K
5ib5si iw
20 May 11
Other Events
12:00am
8-K
1k3amrtls5yce5diw8
17 May 11
Dose-related efficacy and optimal once-daily dosing interval of the long-acting beta2
12:00am
8-K
g0muu7 kt8f65q6
16 May 11
Other Events
12:00am
8-K
6qgzr4g0d
2 May 11
Submission of Matters to a Vote of Security Holders
12:00am
8-K
0geduvs
28 Apr 11
Results of Operations and Financial Condition
12:00am